What's breaking now, across thousands of outlets.
FDA regulators said they’re open to “innovative approaches” for studying the effects of psychedelic therapies, including the use of comparators other than placebo. The comments echo recently finalized regulatory guidance and signal ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- In "Beyond Diagnosis: Metastatic Castration-Sensitive Prostate Cancer," Cleveland Clinic oncologist Christopher Wee, MD, and host John Mangels discuss how clinicians can guide…
Two days into hearing the stories of people who had adverse reactions to the COVID-19 shot, some media is still not acknowledging that not everything went as well as government and health officials…
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Is this a horse or a newborn baby?
A new study showed that a prgrammed lysis approach cut mechanical separation energy by over 50 percent at pilot scale, widening the range of bioalternatives that can compete pricewise.
